AllaKeyznerMD

Oncology • New York, NY

Assistant Professor, Medicine, Mount Sinai School Of Medicine, Associate Director, Allogeneic BMT

Join to view full profile

Dr. Keyzner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keyzner's full profile

Already have an account?

Office
10 E 102nd St
New York, NY 10029
Phone+1 212-241-6756

Fax+1 212-423-0522

Education & Training

Mayo Clinic College of Medicine and ScienceFellowship, Blood & Bone Marrow Transplant, 2009 - 2010
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2006 - 2009
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2006
Drexel University College of MedicineClass of 2003

Certifications & Licensure

NY State Medical License 2004 - 2026
MN State Medical License 2009 - 2010
American Board of Internal Medicine Hematology

Clinical Trials

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2010 Feb 01
Completed
Phase 2
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Start of enrollment: 2010 Jul 15
Completed
Phase 2
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Completed
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia.
Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya
American Journal of Hematology. 2024-10-01
Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilo...
Samantha E Jacobs, Uroosa Ibrahim, Akasha Barreto Vega, Jonathan Lagdameo, Jacquelyn Callahan
Transplant Infectious Disease. 2024-06-01
4 citations
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos
Haematologica. 2023-12-01

Abstracts/Posters

No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...
Alla Keyzner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Professional Memberships

American Society of Hematology - ASH
Member
American Society for Blood and Marrow Marrow Transplantation
Member

Other Languages

Russian